Drug intelligence / Profile preview

tuberoinfundibular peptide of 39 residues

Development stage
Preclinical
Modality
Hormonal Peptides → Native Peptides → Peptides, Recombinant Proteins and Enzymes
Administration
Intrathecal, Intracerebroventricular, Intravenous, Subcutaneous, Intraperitoneal
01

Overview

Tuberoinfundibular peptide of 39 residues (TIP39) is a naturally occurring neuropeptide and the endogenous ligand for the parathyroid hormone 2 receptor (PTH2R). It is a polypeptide consisting of 39 amino acids and is encoded by the PTH2 gene in humans. TIP39 acts as a potent and selective agonist at PTH2R, with high affinity and efficacy in both human and rat receptors. Its primary physiological roles include regulation of pituitary hormone secretion and modulation of pain perception via spinal cord circuits. TIP39 has also been implicated in social behavior regulation based on animal studies. Structurally, it shares some homology with parathyroid hormone but displays unique features that confer selectivity for PTH2R over other related receptors[1][3][6][7].

Other names
tuberoinfundibular neuropeptideparathyroid hormone 2PTH2PTH-2PTH 2Tuberoinfundibular 39 residue proteinTuberoinfundibular39 residue proteinTuberoinfundibular-39 residue protein
02

Targets

PTH2R (Parathyroid hormone 2 receptor)PTH1R (Parathyroid hormone/Parathyroid hormone-related peptide receptor type 1)

Beyond the preview

Go deeper on tuberoinfundibular peptide of 39 residues.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tuberoinfundibular peptide of 39 residues.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call